Connection
Jawahar Mehta to Benzimidazoles
This is a "connection" page, showing publications Jawahar Mehta has written about Benzimidazoles.
|
|
Connection Strength |
|
|
|
|
|
0.504 |
|
|
|
-
Chen J, Li D, Schaefer R, Mehta JL. Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan. Atherosclerosis. 2006 Feb; 184(2):295-301.
Score: 0.251
-
Chen J, Li D, Schaefer RF, Mehta JL. Inhibitory effect of candesartan and rosuvastatin on CD40 and MMPs expression in apo-E knockout mice: novel insights into the role of RAS and dyslipidemia in atherogenesis. J Cardiovasc Pharmacol. 2004 Oct; 44(4):446-52.
Score: 0.238
-
Chen K, Mehta JL, Li D, Joseph L, Joseph J. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II. Circ Res. 2004 Dec 10; 95(12):1167-73.
Score: 0.015